11 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Planmeca Viso

FDA 510(k)
FDA Class 2 ·Radiology

Lumipulse G Specimen Diluent 2

FDA UDI
FUJIREBIO INC.·04987270230985·

1717FCC

FDA 510(k)
FDA Class 2 ·Radiology

BREAS PV 10I CPAP SYSTEM, MODEL PV 10I

FDA 510(k)
FDA Class 2 ·Anesthesiology

CORFLO CUBBY LOW PROFILE GASTROSTOMY DEVICE

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORPORATION·Product code KNT·October 28, 2008

DUAL SPEED CEMENT INJECTION GUN

FDA Adverse Event
Malfunction ·STRYKER INSTRUMENTS KALAMAZOO·Product code JDZ·July 19, 2011

1.8MM TI LOCKING SCREW

FDA Adverse Event
Injury ·SYNTHES USA·Product code KWP·July 17, 2013

i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300

FDA Enforcement
Class II ·Ongoing·Abbott Point Of Care Inc.·September 24, 2025

Rebstock Holding rod for fixation -For holding and fixation of flexible Leyla Arms and spatula Art. No. 06-06-285 and 06-06-285MOD. surgical instrument.

FDA Enforcement
Class II ·Ongoing·Medagent Inc·March 6, 2024

i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300

FDA Recall
Open, Classified ·Abbott Point Of Care Inc.·Product code CHL·August 21, 2025

Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled selective infusion of physician-specified therapeutics agents such as embolization materials and of diagnostic materials such as contrast media. UltraFlow HPC Flow: The device is intended for the controlled selective infusion of physician-specified pharmacologic agents or contrast media into the distal vasculature of the peripheral and neuroanatomy. It is not intended for use in the coronary vasculature. Catalog No. 105-5055V02 105-5055V02 105-5055V05 105-5065V02 105-5065V05 105-5066V02 105-5066V05

FDA Enforcement
Class I ·Terminated·Micro Therapeutics Inc, Dba Ev3 Neurovascular·November 16, 2016